P/E ratio for SIGA Technologies (SIGA)
P/E ratio as of April 2024 (TTM): 23.1
According to SIGA Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.1053. At the end of 2022 the company had a P/E ratio of 16.2.
P/E ratio history for SIGA Technologies from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 16.2 | 98.35% |
| 2021 | 8.15 | -19.24% |
| 2020 | 10.1 | -119.05% |
| 2019 | -53.0 | -3622.15% |
| 2018 | 1.50 | -114.27% |
| 2017 | -10.5 | 152.6% |
| 2016 | -4.17 | 615.53% |
| 2015 | -0.5833 | 100.93% |
| 2014 | -0.2903 | -97.16% |
| 2013 | -10.2 | 5.31% |
| 2012 | -9.70 | -319.49% |
| 2011 | 4.42 | -135.37% |
| 2010 | -12.5 | -7.33% |
| 2009 | -13.5 | 7.25% |
| 2008 | -12.6 | -30.58% |
| 2007 | -18.1 | 69.1% |
| 2006 | -10.7 | 12.78% |
| 2005 | -9.50 | 128.92% |
| 2004 | -4.15 | -38.38% |
| 2003 | -6.74 | 46.01% |
| 2002 | -4.61 | -30.01% |
| 2001 | -6.59 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | -16.5 | -171.30% | 🇺🇸 USA |
 Novavax NVAX | -0.5685 | -102.46% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -15.1 | -165.46% | 🇺🇸 USA |
 NanoViricides NNVC | -1.86 | -108.07% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -3.33 | -114.42% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -0.1589 | -100.69% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.